Company Overview of Sirion Therapeutics, Inc.
Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical company, engages in the discovery, development, and commercialization of products for the protection and preservation of eyesight. It develops Durezol, a topical steroid for postoperative inflammation and pain, as well as for uveitis; ganciclovir, a topical antiviral for herpetic keratitis; cyclosporine, a topical immunomodulator for dry eye; fenretinide, an oral vitamin A binding protein antagonist for geographic atrophy associated with dry AMD; and Zirgan, a ganciclovir ophthalmic gel for acute herpetic keratitis. The company was incorporated in 2005 and is based in Tampa, Florida. Sirion Therapeutics, Inc. is a subsidiary ...
3110 Cherry Palm Drive
Tampa, FL 33619
Founded in 2005
Key Executives for Sirion Therapeutics, Inc.
Co-Founder, Chief Executive Officer, President and Director
Co-Founder and Senior Vice President of Business Development
Co-Founder and Senior Vice President of Sales & Marketing
Chief Scientific Officer and Senior Vice President of Discovery Research
Senior Vice President of Drug Development
Compensation as of Fiscal Year 2014.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries